Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API


logo
Adjuvant Capital logo

Adjuvant Capital

Investments
30
Lead Investments
10

Adjuvant Capital is a life sciences investment firm focused on global health. The company makes $10-$25 million investments in ambitious companies targeting opportunities in high burden and neglected disease. Adjuvant Capital was founded in 2012 by Charlie Petty, Glenn Rockman, and Kabeer Aziz and is based in New York.

Founded 2012
North America, United States
11-50
adjuvantcapital.com

Highlights

Focus Areas

Biotechnology
Health Care
Medical
Life Science
Biopharma

Investment Types

Convertible Note
Early Stage Venture
Late Stage Venture

Notable Investments

Orange Dental logo
LakeShore Biopharma logo
Curevo logo
Pulmocide logo
Minervax logo
Excision BioTherapeutics logo
X-Vax Technology logo
Antiva Biosciences logo
Themis Bioscience logo
Memo Therapeutics logo
LimmaTech Biologics logo
54gene logo
Codagenix logo
VitriVax logo
AN2 Therapeutics logo

Investment History

Team